Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Massimo Martino, Francesco Lanza, Taner Demirer, Tiziana Moscato, Simona Secondino & Paolo Pedrazzoli. (2015) Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation. Expert Opinion on Biological Therapy 15:2, pages 195-211.
Read now
Read now
Loraine Derbyshire Colin W Thain. (2013) Managing chemotherapy induced anemia with darbepoetin alfa and other erythropoiesis stimulating agents: a nurse's perspective. Nursing: Research and Reviews 3, pages 155-162.
Read now
Read now
Ruth Pettengell, Antonio Salar Silvestre, Matthias Schwenkglenks, Francesca Gaia Rossi, Ulrich Duehrsen, Gregor Verhoef, Pieternella Johanna Lugtenburg, Tracey Wheeler, Beatriz Pujol & Corinne Haioun. (2013) Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R)CHOP. Hematology 18:1, pages 26-29.
Read now
Read now
Articles from other publishers (8)
Nancy L. Bartlett. (2020) Approaches to aggressive B-cell lymphomas in less fit patients. Hematology 2020:1, pages 140-147.
Crossref
Crossref
Eugenio Galli, Annarosa Cuccaro, Elena Maiolo, Silvia Bellesi, Francesco D'Alò, Domenico Fusco, Giuseppe Colloca, Valerio De Stefano & Stefan Hohaus. (2020) Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma. Hematological Oncology 38:2, pages 153-161.
Crossref
Crossref
Bo Peng, Gangcheng Kong, Cheng Yang & Yingzi Ming. (2020) Erythropoietin and its derivatives: from tissue protection to immune regulation. Cell Death & Disease 11:2.
Crossref
Crossref
Julia Bohlius, Kari Bohlke, Roberto Castelli, Benjamin Djulbegovic, Maryam B. Lustberg, Massimo Martino, Giannis Mountzios, Namrata Peswani, Laura Porter, Tiffany N. Tanaka, Gianluca Trifirò, Hushan Yang & Alejandro Lazo-Langner. (2019) Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update. Journal of Clinical Oncology 37:15, pages 1336-1351.
Crossref
Crossref
Julia BohliusKari BohlkeRoberto CastelliBenjamin DjulbegovicMaryam B. LustbergMassimo MartinoGiannis MountziosNamrata PeswaniLaura PorterTiffany N. TanakaGianluca TrifiròHushan Yang & Alejandro Lazo-Langner. (2019) Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update. Blood Advances 3:8, pages 1197-1210.
Crossref
Crossref
Robert Pirker, Michael Hedenus, Johan Vansteenkiste, Enrique Hernandez, Laura Belton & Jan-Henrik Terwey. (2016) Effectiveness of Darbepoetin Alfa for Chemotherapy-induced Anemia When Initiated at Hemoglobin ≤10 g/dL. Clinical Therapeutics 38:1, pages 122-135.e6.
Crossref
Crossref
M. Hultcrantz, R.M. Pfeiffer, M. Björkholm, L.R. Goldin, I. Turesson, S. Schulman, O. Landgren & S.Y. Kristinsson. (2014) Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. Journal of Thrombosis and Haemostasis 12:11, pages 1816-1821.
Crossref
Crossref
Michael Hedenus, Heinz Ludwig, David H. Henry & Eduard Gasal. (2014) Pharmacovigilance in practice: erythropoiesis‐stimulating agents. Cancer Medicine 3:5, pages 1416-1429.
Crossref
Crossref